Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05805176 · ClinicalTrials.gov registry record · NA
An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms
A NA study of ADHD, sponsored by Lumos Labs.
- Active
- Registry status
- NA
- Development phase
- 194
- Enrollment target
- 5
- Study locations
NCT05805176: Active NA study of ADHD, sponsored by Lumos Labs.
NCT05805176 is a NA study of ADHD that is active but no longer recruiting, run by Lumos Labs. The registered enrollment target is 194 participants, roughly in line with the 188-participant average among 75 other ADHD trials with a reported enrollment target. The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05805176, a NA study of ADHD, is active but no longer recruiting, sponsored by Lumos Labs.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 194 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objective of this study is to assess the safety and effectiveness of an at-home, game-based digital therapy for treating adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD).
Primary Outcome
The Conners' Adult ADHD Rating Scales-Investigator Rated: Long Version (CAARS-Inv:L) has 66 items with multiple subscales.
Conditions Studied
Interventions
- DEVICE ADHD Therapy
Study Locations (5)
Florida
- CNS Healthcare of Jacksonville - Jacksonville
- Accel Clinical Research Sites - Lakeland
Michigan
- Rochester Center for Behavioral Medicine (RCBM) - Rochester Hills
Missouri
- Midwest Research Group - Brentwood
New Jersey
- Hassman Research Institute - Berlin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2023-04-15 |
| Est. Completion | 2025-06 |
| Phase | NA |
What the registry record for NCT05805176 still lists
NCT05805176 is an interventional study that assigns participants to a tested intervention. The registered 194 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 188-participant average among 75 other ADHD trials with a reported enrollment target.
The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 1 intervention - of which ADHD Therapy is the first listed.
NCT05805176 lists 5 locations in 4 states (Florida, Michigan, Missouri).
Frequently Asked Questions
What is clinical trial NCT05805176 about?
NCT05805176 is a clinical study titled "An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms". The objective of this study is to assess the safety and effectiveness of an at-home, game-based digital therapy for treating adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD).
What is the current status of trial NCT05805176?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 194 participants. The study started on 2023-04-15. Estimated completion is 2025-06.
What conditions does trial NCT05805176 study?
This clinical trial studies the following conditions: ADHD.
What interventions are being tested in trial NCT05805176?
The interventions under investigation include: ADHD Therapy (DEVICE).
Who is sponsoring clinical trial NCT05805176?
This trial is sponsored by Lumos Labs, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05805176 being conducted?
This trial has 5 study locations across Florida, Michigan, Missouri, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05805176's enrollment target sits among peer trials
194 23rd of 75 higher than 53 of 75 other ADHD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Target ADHD Executive Working Memory Replication Study
RECRUITING · NA
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Fidgeting and Attentional and Emotional Regulation in ADHD
RECRUITING · NA
-
Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study
RECRUITING · NA
-
A Pilot Study of a Remote ADHD Monitoring Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
- NCT05351424 · 194 participants · NA
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI